# Resilience US, Inc. – FDA Inspection, Mar 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/resilience-us-inc/5e71df58-ca79-476d-af51-50ceee60d664
Source feed: FDA_Inspections

> FDA inspection 1043914 of Resilience US, Inc., March 08, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1043914
- Company Name: Resilience US, Inc.
- Inspection Date: 2018-03-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1258820 - 2025-01-21](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/3def6d42-7ce3-4bf9-bc57-c421ba00c6c1)
- [FDA Inspection 1099149 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/e75da02d-7e51-4694-8e06-35b05dac8388)
- FDA Inspection 1028106 - 2017-09-07
- [FDA Inspection 1018002 - 2017-06-27](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/e512d02e-e89d-4a88-8da6-8104c6c495fb)
- FDA Inspection 983420 - 2016-08-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lauren-n-howard/538f77fe-b977-49c9-a5b3-289cf8a6e886)
- [Company Rep](https://www.keypedia.com/people/lianji-jin/e8e5df93-02ee-45a3-9103-e3089d34b02a)
- [Company Rep](https://www.keypedia.com/people/lindsey-s-fleischman/19ba1e93-b804-487c-8c34-68dc703b0013)

Company: https://www.keypedia.com/companies/resilience-us-inc/864cabb1-d73c-4706-8d04-3e5c2375f44e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
